Table 5 Association of pre-transplant panel reactive antibody with potential BOS
|  | BOS 0 (n = 14) | ≥pBOS (n = 6) | p-value |
|---|---|---|---|
Total | Â | Â | Â |
cPRA |  |  | > 0.999 |
 Not detected or PRA < 50%, n (%) | 12 (85.7) | 5 (83.3) |  |
 PRA ≥ 50%, n (%) | 2 (14.3) | 1 (16.7) |  |
Anti-HLA Ab (MFI) | Â | Â | 0.131 |
 Not detected or MFI < 3000, n (%) | 12 (85.7) | 3 (50) |  |
 MFI ≥ 3000, n (%) | 2 (14.3) | 3 (50) |  |
Class I | Â | Â | Â |
cPRA |  |  | > 0.999 |
 Not detected or PRA < 50%, n (%) | 12 (85.7) | 5 (83.3) |  |
 PRA ≥ 50%, n (%) | 2 (14.3) | 1 (16.7) |  |
Class I anti-HLA Ab (MFI) | Â | Â | 0.549 |
 Not detected or MFI < 3000, n (%) | 12 (85.7) | 4 (66.7) |  |
 MFI ≥ 3000, n (%) | 2 (14.3) | 2 (33.3) |  |
Class II | Â | Â | Â |
cPRA |  |  | – |
 Not detected or PRA < 50%, n (%) | 14 (100) | 6 (100) |  |
 PRA ≥ 50%, n (%) | – | – |  |
Class II anti-HLA Ab (MFI) | Â | Â | 0.079 |
 Not detected or MFI < 3000, n (%) | 14 (100) | 4 (66.7) |  |
 MFI ≥ 3000, n (%) | 0 (0) | 2 (33.3) |  |
Donor Specific Antibody |  |  | > 0.999 |
 Yes, n (%) | 2 (14.3) | 1 (16.7) |  |
 No, n (%) | 12 (85.7) | 5 (83.3) |  |
CMV status | Â | Â | Â |
 Donor + / Recipient -, n (%) | 0 (0) | 0 (0) | – |
 Donor + / Recipient +, n (%) | 14 (100) | 6 (100) | – |
Donor BAL culture +, n (%) | 9 (64.3) | 2 (33.3) | 0.336 |
Pseudomonas aeruginosa colonization, n (%) | 1 (7.1) | 1 (16.7) | 0.521 |
Ischemic time, min (mean ± SD) | 213.2 ± 62.8 | 197.0 ± 55.6 | 0.386 |